(secondQuint)TLC D-99 and Ifosfamide in Metastatic Soft Tissue Sarcoma Patients.

 The Maximum Tolerated Dose of the combination was determined and the Phase I terminated.

 Then, Phase II study started.

.

 TLC D-99 and Ifosfamide in Metastatic Soft Tissue Sarcoma Patients@highlight

The purpose of this study is to determine the maximum tolerated dose of the TLC D-99 combined with ifosfamide and then the efficacy of this combination in terms of overall response rate, time to progression and time of response